SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Tersedia dari:

Boston Scientific Pty Ltd

Kelas:

Class III

Diproduksi oleh:

Boston Scientific Corporation 300 Boston Scientific Way, Marlborough, MA, 01752 United States Of America

Area terapi:

58771 - Drug-eluting coronary artery stent, biodegradable-polymer-coated

Indikasi Terapi:

The SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System is mounted on a balloon expandable delivery catheter, is inserted percutaneously and advanced through the vasculature to the site of the lesion. The balloon is then inflated to expand the stent to the appropriate diameter. Finally, the balloon is deflated and the balloon catheter removed, leaving the stent in position. The SYNERGY Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease, including patients with acute myocardial infarction, due to discrete de novo native coronary artery lesions. This device is MR conditional.

Status otorisasi:

A

Tanggal Otorisasi:

2014-02-21